- Active Surveillance
- Administrative Data
- Research Methods
- Health Services and Policy/Pharmaceutical Policy
- Clinical Therapeutics
- Knowledge Translation/Implementation Science
- Population Health, Epidemiology and Biostatistics
- Professor, Department of Medicine, Division of Clinical Pharmacology and Therapeutics, Department of Clinical Epidemiology and Biostatistics, McMaster University
- Active Staff, St. Joseph’s Healthcare Hamilton
- Director, Centre for Evaluation of Medicines, St. Joseph’s Healthcare Hamilton
- Director, Programs for Assessment of Technology in Health (PATH), St. Joseph’s Healthcare Hamilton
Dr. Mitchell Levine received his medical degree from the University of Calgary which was followed by postgraduate training in Internal Medicine (FRCPC) and Clinical Pharmacology at the University of Toronto and an MSc degree in Clinical Epidemiology from McMaster University.
Mitchell is the Director of the Centre for Evaluation of Medicines and Director of the Programs for Assessing Technology in Health (PATH) at St. Joseph’s Healthcare, Hamilton. He holds the position of Professor at McMaster University in the Department of Clinical Epidemiology & Biostatistics and the Department of Medicine, in the Division of Clinical Pharmacology. He is a practicing consultant physician in Internal Medicine and Clinical Pharmacology.
In 2011 Mitchell was appointed as the Vice-Chair of the Patented Medicine Prices Review Board. He also serves as a consultant to the Ontario Drug Benefits program and is a member of the Scientific Advisory Committee on Pharmaceutical Sciences and Clinical Pharmacology for Health Canada. He is the Editor-in-Chief for the Journal of Population Therapeutics and Clinical Pharmacology, the Canadian Journal of General Internal Medicine, and Associate Editor of the ACP Journal Club and Evidence-Based Medicine.
Assessing prescription drug use in the community and developing methods for promoting cost-effective use of drug therapy are Mitchell’s principal research interests. This involves collecting data on how drugs are actually used in the community, and the impact they have on health care resource use and on patient quality of life. Research is also conducted to help determine how both patient and healthcare provider value systems influence the use of drug therapies in clinical practice.